Skip to main content
Toggle navigation
Login
Search
Home
Tweets by AACE 2023
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Email
Tweet this
Print
Robert J. Holt, PharmD
Group Vice President, Scientific Communications and Outcomes Research
Horizon Therapeutics
Poster(s):
Assessment of the Thyroid Eye Disease Specific Graves’ Ophthalmopathy Quality of Life Questionnaire in Non-Inflammatory or Inactive Thyroid Eye Disease Patients
Friday, May 5, 2023
10:25 AM – 10:40 AM
Hearing-Related Adverse Events and Quality of Life Assessments in Thyroid Eye Disease Patients Treated with Teprotumumab
Friday, May 5, 2023
11:55 AM – 12:10 PM
Email Robert